Low Fecal Calprotectin Predicts Histological Healing in Patients with Ulcerative Colitis with Endoscopic Remission and Leads to Prolonged Clinical Remission (vol 29, pg 359, 2023)

被引:0
|
作者
Kawashima, Kousaku
Oshima, Naoki
Kishimoto, Kenichi
Kataoka, Masatoshi
Fukunaga, Mai
Kotani, Satoshi
Sonoyama, Hiroki
Oka, Akihiko
Mishima, Yoshiyuki
Kazumori, Hideaki
Ishikawa, Noriyoshi
Araki, Asuka
Ishihara, Shunji
机构
关键词
D O I
10.1093/ibd/izad261
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:2013 / 2013
页数:1
相关论文
共 50 条
  • [41] THE POTENTIAL OF MOLECULAR REMISSION: TISSUE NEUTROPHIL ELASTASE IS BETTER THAN HISTOLOGICAL ACTIVITY FOR PREDICTING LONG-TERM RELAPSE IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL AND ENDOSCOPIC REMISSION
    Jun, Yu Kyung
    Lee, Ji Ae
    Choi, Yonghoon
    Shin, Cheol Min
    Park, Young Soo
    Kim, Nayoung
    Lee, Dong Ho
    Oh, Hyeon Jeong
    Yoon, Hyuk
    GASTROENTEROLOGY, 2024, 166 (05) : S519 - S520
  • [42] Endoscopic score vs. faecal biomarkers for predicting relapse in patients with ulcerative colitis after clinical remission and mucosal healing
    Yamamoto, T.
    Shimoyama, T.
    Umegae, S.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S225 - S226
  • [43] EFFECT OF HISTOLOGICAL ACTIVITY ON CLINICAL OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS TREATED-TO-TARGET: COMPARISON OF CLINICAL VS ENDOSCOPIC VS HISTOLOGIC REMISSION
    Jangi, Sushrut
    Yoon, Hyuk
    Dulai, Parambir
    Boland, Brigid S.
    Valasek, Mark A.
    Jairath, Vipul
    Feagan, Brian G.
    Sandborn, William J.
    Singh, Siddharth
    GASTROENTEROLOGY, 2020, 158 (06) : S698 - S698
  • [44] Disease clearance prevents negative outcomes in ulcerative colitis patients and enhances the impact of independently achieving clinical, endoscopic, or histological remission.
    Lopez, L. Ramos
    de la Barreda, R.
    Nicolas-Perez, D.
    Quintero, E.
    Hernandez-Guerra, M.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i236 - i237
  • [45] Reduction of Fecal Calprotectin Levels Induced by a Short Course of Escherichia Coli Nissle is Associated with a Lower Likelihood of Disease Flares in Patients with Ulcerative Colitis in Clinical Remission
    Bodini, Giorgia
    Ghezzi, Andrea
    Pasta, Andrea
    Marabotto, Elisa
    Calabrese, Francesco
    Facchini, Chiara
    Demarzo, Maria Giulia
    Giannini, Edoardo G.
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2023, 32 (04) : 438 - 443
  • [46] Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis (vol 9, e002058, 2021)
    Zou, Fangwen
    Wang, Xuemei
    Oliva, Isabella C. Glitza
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (03) : 1 - 1
  • [47] Normalization or reduction of at least 50% in faecal calprotectin levels after 3 months of treatment predicts clinical and endoscopic remission at 1 year in patients with ulcerative colitis: results of the prospective MIROIR study
    Buisson, A.
    Coban, D.
    Bazoge, M.
    Dodel, M.
    Pereira, B.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i863 - i863
  • [48] Histological Remission Leads to Less Endoscopic Flare-up in Moderate-to-Severe, Biologics Experienced Ulcerative Colitis Patients: A Comprehensive Retrospective Cohort Study
    Wei, Z. H.
    Le, P. H.
    Chiu, H. Y.
    Yeh, P. J.
    Chiu, C. T.
    Chiu, C. H.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1119 - I1121
  • [49] FAECAL CALPROTECTIN TO PREDICT THE RISK OF RELAPSE IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL REMISSION AND ENDOSCOPIC MAYO SCORE 0 OR 1: RESULTS OF THE CALPRODICT-UC STUDY
    Buisson, Anthony
    Carpentier, Constantin
    Minet-Quinard, Regine
    Pereira, Bruno
    GASTROENTEROLOGY, 2023, 164 (06) : S884 - S884
  • [50] A disease model predicting placebo response and remission status of patients with ulcerative colitis using modified Mayo score (vol 16, pg 2310, 2023)
    Moein, A.
    Langenhorst, J.
    Plan, E. L.
    Jin, J. Y.
    Kagedal, M.
    Kassir, N.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (05):